// App-Quantinova.ai

Tu1119 : Responsiveness of Central Endoscopic Assessment of Disease Activity Using the Modified Mayo Clinic Score in Ulcerative Colitis

Researchers

Presenter

  • Suresh Pola

Principal Investigators

  • Debra King

  • Geert R. -Haens

  • John W. McDonald

  • Guangyong Zou

  • William Sandborn

  • Brian G. Feagan

Medical Centers

  • Academic Medical Center, Amsterdam, Netherlands

  • Robarts Clinical Trials, London, Ontario, Canada

  • Division of Pediatric Nephrology, University of California at San Diego, La Jolla, CA

  • Gastroenterology, University of Western Ontario, London, Ontario, Canada

Locations

  • United States

  • Canada

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Mesalamine

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim